SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Robert Baughman, MD

Professor of Pulmonary Medicine
University of Cincinnati
Cincinnati, OH

Title
: Identifying and Managing Patients with Sarcoidosis
Activity/Course #:
: NCME319
Cost:
: Free
Release/Start Date:
: Feb 20 2017
Expiration Date:
: Feb 19 2018
Topics:
: Pulmonology
Target Audience:
: Primary Care Providers
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s)
Hardware/Software Requirements:
Welcome to the National Association for Continuing Education webcast from the NACE Challenges in Pulmonary and Critical Care 2016 conference. The topic of this webcast is Identifying and Managing Patients with Sarcoidosis and features Robert Baughman, MD.

Learning Objective(s):

After completing this program participants should be able to:

  1. Describe the pathophysiology and the epidemiology of Sarcoidosis.
  2. Discuss the up-to-date methodology for diagnosis of Sarcoidosis.
  3. Explain our current understanding of the treatments considered, including steroids, mineralocorticoid receptor agonists and other agents.

This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Robert Baughman, MD, Speaker, has the following relationships to disclose: P.I. Research Study - Mallinckrodt; Gilead; Bayer; Astra Zeneca.

Franck Rahaghi, MD, MHS, FCCP, Course Director, has the following relationship to disclose: Speaker/ Consultant/ Researcher - Actelion; Bayer; Gilead; United Therapeutics.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.; an educational grant from Baxalta US Inc.; the activity has been supported (in part) by an educational grant from Bayer Healthcare Pharmaceuticals Inc.; an educational grant from Biodesix; an educational grant from Bristol-Myers Squibb Company; an unrestricted educational grant from CSL Behring; an educational grant from Grifols; and an educational grant from Mallinckrodt Pharmaceuticals.